Gene · 2176
Papers2,586
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 2,586
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Esophageal Atresia With or Without Tracheoesophageal Fistula: Comorbidities, Genetic Evaluations, and Neonatal Outcomes. | Cureus | 2023 | 36909054 | PubTator, text mining | PubMed |
| Multidimensional outlook on the pathophysiology of cervical cancer invasion and metastasis. | Mol Cell Biochem | 2023 | 36905477 | PubTator, text mining | PubMed |
| Development and Experimental Validation of a Novel Prognostic Signature for Gastric Cancer. | Cancers (Basel) | 2023 | 36900401 | PubTator, text mining | PubMed |
| Rare germline variants in pancreatic cancer and multiple primary cancers: an autopsy study. | Eur J Cancer Prev | 2023 | 36896836 | PubTator, text mining | PubMed |
| Comprehensive laboratory diagnosis of Fanconi anaemia: comparison of cellular and molecular analysis. | J Med Genet | 2023 | 36894310 | PubTator, text mining | PubMed |
| Gonadal function in pediatric Fanconi anemia patients treated with hematopoietic stem cell transplant. | Haematologica | 2023 | 36891729 | PubTator, text mining | PubMed |
| Emerging role of miRNAs in the regulation of ferroptosis. | Front Mol Biosci | 2023 | 36876051 | PubTator, text mining | PubMed |
Proprioceptors-enriched neuronal cultures from induced pluripotent stem cells from Friedreich ataxia patients show altered transcriptomic and proteomic profiles, abnormal neurite extension, and impaired electrophysiological properties. | Brain Commun | 2023 | 36865673 | PubTator, text mining | PubMed |
| Association between homologous recombination deficiency and outcomes with platinum and platinum-free chemotherapy in patients with triple-negative breast cancer. | Cancer Biol Med | 2023 | 36861447 | PubTator, text mining | PubMed |
| Molecular characterisation of 36 multilocus imprinting disturbance (MLID) patients: a comprehensive approach. | Clin Epigenetics | 2023 | 36859312 | PubTator, text mining | PubMed |
| The cancer-risk variant frequency among Polish population reported by the first national whole-genome sequencing study. | Front Oncol | 2023 | 36845707 | PubTator, text mining | PubMed |
| Homologous Recombination Deficiency in Ovarian Cancer: from the Biological Rationale to Current Diagnostic Approaches. | J Pers Med | 2023 | 36836518 | PubTator, text mining | PubMed |
| Molecular Genetic Characteristics of FANCI, a Proposed New Ovarian Cancer Predisposing Gene. | Genes (Basel) | 2023 | 36833203 | PubTator, text mining | PubMed |
| Approaches to Clinical Complete Response after Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer: Possibilities and Limitations. | Cancers (Basel) | 2023 | 36831665 | PubTator, text mining | PubMed |
| An Insight on Functioning Pancreatic Neuroendocrine Neoplasms. | Biomedicines | 2023 | 36830839 | PubTator, text mining | PubMed |
| Dynamic Regulation of DNA Methylation and Brain Functions. | Biology (Basel) | 2023 | 36829430 | PubTator, text mining | PubMed |
| Response to correspondence to "Temporal trends and outcomes of peripheral artery disease revascularization and amputation among the HIV population". | AIDS | 2023 | 36815527 | PubTator, text mining | PubMed |
| Variability and genetic merits of white Guinea yam landraces in Nigeria. | Front Plant Sci | 2023 | 36814760 | PubTator, text mining | PubMed |
| The repertoire of copy number alteration signatures in human cancer. | Brief Bioinform | 2023 | 36806386 | PubTator, text mining | PubMed |
| Functional Homologous Recombination Assay on FFPE Specimens of Advanced High-Grade Serous Ovarian Cancer Predicts Clinical Outcomes. | Clin Cancer Res | 2023 | 36805632 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2176/papers?page=15